Reuters logo
BRIEF-Flexion Therapeutics announces NDA for Zilretta accepted by U.S. FDA
February 7, 2017 / 12:50 PM / 10 months ago

BRIEF-Flexion Therapeutics announces NDA for Zilretta accepted by U.S. FDA

Feb 7 (Reuters) - Flexion Therapeutics Inc :

* Flexion Therapeutics announces new drug application for Zilretta (fx006) accepted by U.S. Food and Drug Administration

* Flexion Therapeutics Inc - agency has established a user fee goal date under prescription drug user fee act (PDUFA) of October 6, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below